These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16596167)

  • 1. PRKCA and multiple sclerosis: association in two independent populations.
    Saarela J; Kallio SP; Chen D; Montpetit A; Jokiaho A; Choi E; Asselta R; Bronnikov D; Lincoln MR; Sadovnick AD; Tienari PJ; Koivisto K; Palotie A; Ebers GC; Hudson TJ; Peltonen L
    PLoS Genet; 2006 Mar; 2(3):e42. PubMed ID: 16596167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population.
    Barton A; Woolmore JA; Ward D; Eyre S; Hinks A; Ollier WE; Strange RC; Fryer AA; John S; Hawkins CP; Worthington J
    Brain; 2004 Aug; 127(Pt 8):1717-22. PubMed ID: 15155525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.
    Paraboschi EM; Rimoldi V; Soldà G; Tabaglio T; Dall'Osso C; Saba E; Vigliano M; Salviati A; Leone M; Benedetti MD; Fornasari D; Saarela J; De Jager PL; Patsopoulos NA; D'Alfonso S; Gemmati D; Duga S; Asselta R
    Hum Mol Genet; 2014 Dec; 23(25):6746-61. PubMed ID: 25080502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24.
    Saarela J; Schoenberg Fejzo M; Chen D; Finnilä S; Parkkonen M; Kuokkanen S; Sobel E; Tienari PJ; Sumelahti ML; Wikström J; Elovaara I; Koivisto K; Pirttilä T; Reunanen M; Palotie A; Peltonen L
    Hum Mol Genet; 2002 Sep; 11(19):2257-67. PubMed ID: 12217954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha.
    Carroll LS; Williams NM; Moskvina V; Russell E; Norton N; Williams HJ; Peirce T; Georgieva L; Dwyer S; Grozeva D; Greene E; Farmer A; McGuffin P; Morris DW; Corvin A; Gill M; Rujescu D; Sham P; Holmans P; Jones I; Kirov G; Craddock N; O'Donovan MC; Owen MJ
    Mol Psychiatry; 2010 Nov; 15(11):1101-11. PubMed ID: 19786960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory Variants Modulate Protein Kinase C α (PRKCA) Gene Expression in Human Heart.
    Li L; Zhang L; Binkley PF; Sadee W; Wang D
    Pharm Res; 2017 Aug; 34(8):1648-1657. PubMed ID: 28120175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Reduction in Left Ventricular Protein Kinase C-α and Adverse Ventricular Remodeling in Human Subjects.
    Hu R; Morley MP; Brandimarto J; Tucker NR; Parsons VA; Zhao SD; Meder B; Katus HA; Rühle F; Stoll M; Villard E; Cambien F; Lin H; Smith NL; Felix JF; Vasan RS; van der Harst P; Newton-Cheh C; Li J; Kim CE; Hakonarson H; Hannenhalli S; Ashley EA; Moravec CS; Tang WHW; Maillet M; Molkentin JD; Ellinor PT; Margulies KB; Cappola TP
    Circ Genom Precis Med; 2018 Mar; 11(3):e001901. PubMed ID: 29540468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of Complex I in multiple sclerosis.
    Vyshkina T; Banisor I; Shugart YY; Leist TP; Kalman B
    J Neurol Sci; 2005 Jan; 228(1):55-64. PubMed ID: 15607211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy.
    D'Alfonso S; Bolognesi E; Guerini FR; Barizzone N; Bocca S; Ferrante D; Castelli L; Bergamaschi L; Agliardi C; Ferrante P; Naldi P; Leone M; Caputo D; Ballerini C; Salvetti M; Galimberti D; Massacesi L; Trojano M; Momigliano-Richiardi P
    Genes Immun; 2008 Jan; 9(1):7-15. PubMed ID: 17928868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to a geographically defined subpopulation in Finland.
    Pihlaja H; Rantamäki T; Wikström J; Sumelahti ML; Laaksonen M; Ilonen J; Ruutiainen J; Pirttilä T; Elovaara I; Reunanen M; Kuokkanen S; Peltonen L; Koivisto K; Tienari PJ
    Genes Immun; 2003 Mar; 4(2):138-46. PubMed ID: 12618862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of two functional single nucleotide polymorphisms of neuropeptide y gene with multiple sclerosis.
    Mohammadi SM; Shirvani Farsani Z; Dosti R; Sahraian MA; Behmanesh M
    Neuropeptides; 2016 Dec; 60():45-50. PubMed ID: 27559040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping of the multiple sclerosis susceptibility locus on 5p14-p12.
    Riise Stensland HM; Saarela J; Bronnikov DO; Parkkonen M; Jokiaho AJ; Palotie A; Tienari PJ; Sumelahti ML; Elovaara I; Koivisto K; Pirttilä T; Reunanen M; Sobel E; Peltonen L
    J Neuroimmunol; 2005 Dec; 170(1-2):122-33. PubMed ID: 16169605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of a MS-associated haplotype encompassing the CCL3 gene.
    Vyshkina T; Kalman B
    J Neuroimmunol; 2006 Jul; 176(1-2):216-8. PubMed ID: 16712957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk alleles for multiple sclerosis in multiplex families.
    D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
    Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS.
    Kallio SP; Jakkula E; Purcell S; Suvela M; Koivisto K; Tienari PJ; Elovaara I; Pirttilä T; Reunanen M; Bronnikov D; Viander M; Meri S; Hillert J; Lundmark F; Harbo HF; Lorentzen AR; De Jager PL; Daly MJ; Hafler DA; Palotie A; Peltonen L; Saarela J
    Hum Mol Genet; 2009 May; 18(9):1670-83. PubMed ID: 19221116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Golli-MBP gene in multiple sclerosis susceptibility.
    Tienari PJ; Kuokkanen S; Pastinen T; Wikström J; Sajantila A; Sandberg-Wollheim M; Palo J; Peltonen L
    J Neuroimmunol; 1998 Jan; 81(1-2):158-67. PubMed ID: 9521617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter polymorphisms and allelic imbalance in ABCB1 expression.
    Loeuillet C; Weale M; Deutsch S; Rotger M; Soranzo N; Wyniger J; Lettre G; Dupré Y; Thuillard D; Beckmann JS; Antonarakis SE; Goldstein DB; Telenti A
    Pharmacogenet Genomics; 2007 Nov; 17(11):951-9. PubMed ID: 18075465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
    Hoffjan S; Okur A; Epplen JT; Wieczorek S; Chan A; Akkad DA
    Int J Immunogenet; 2015 Apr; 42(2):106-10. PubMed ID: 25684197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 19q13 and multiple sclerosis susceptibility in Finland: a linkage and two-stage association study.
    Reunanen K; Finnilä S; Laaksonen M; Sumelahti ML; Wikström J; Pastinen T; Kuokkanen S; Saarela J; Uimari P; Ruutiainen J; Ilonen J; Peltonen L; Tienari PJ
    J Neuroimmunol; 2002 May; 126(1-2):134-42. PubMed ID: 12020965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis.
    Cunningham S; Patterson CC; McDonnell G; Hawkins S; Vandenbroeck K
    Genes Immun; 2005 May; 6(3):265-70. PubMed ID: 15729363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.